Sorry, you need to enable JavaScript to visit this website.
Latest News
October 27, 2020
Bayer appoints Dr. Christian Rommel as new Head of Pharmaceuticals Research and Development
October 26, 2020
Not intended for U.S. and UK Media
Rivaroxaban application submitted to U.S. FDA for new indication in patients after lower-extremity revascularization due to symptomatic PAD
October 26, 2020
Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy
October 23, 2020
Not intended for U.S. and UK Media
FDA approves FoundationOne®CDx as companion diagnostic for Vitrakvi™ (larotrectinib) to aid in identifying NTRK fusion-positive patients
October 23, 2020
Not intended for U.S. and UK Media – Data from Phase III FIDELIO-DKD study presented at the American Society of Nephrology (ASN)’s Kidney Week 2020
Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
Global Health Policy Blog
Current Topics
All